"A showdown is looming in a Florida courtroom over an issue that has long bedeviled business: How much internal information can a company be forced to make public simply because it has become a defendant in a lawsuit?" Read more in BusinessWeek about Astra Zeneca's Seroquel.
Wednesday, February 25, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment